XVIR 210
Alternative Names: NM1TFV; XVIR-210Latest Information Update: 29 Sep 2021
Price :
$50 *
At a glance
- Originator Exavir Therapeutics
- Class Adenine nucleotides; Antiretrovirals; Phosphonic acids; Purines; Small molecules
- Mechanism of Action Nucleotide reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Hepatitis B; HIV infections; Viral infections